WHO ICTRP trial
Effect of probiotic on management of critically ill patients
IRCT201112143320N6 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT201112143320N6 |
|---|---|
| Public title | Effect of probiotic on management of critically ill patients |
| Scientific title | Effect of probiotic containing lactobacillus, bifidobacterium and streptococus thermophilus administration on inflammatory, coagulation and oxidative factors in critically ill patients with risk of sepsis |
| Primary sponsor | Tabriz University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | sepsis. Sepsis, unspecified;Sepsis, unspecified |
| Interventions | Intervention 1: 2 Sachets of probiotic VSL 3 (containing lactobacillus, bifidobacterium and streptococus species)/day for 7 days. Intervention 2: 2 sachet of placebo/day for 7 days.;Treatment - Drugs;Placebo;2 Sachets of probiotic VSL 3… |
| Registration date | Dec 29, 2011 |
| Target size | 40 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: